Hugo CP - Search Results

1

P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis.

Hohenstein B, Renk S, Lang K, Daniel C, Freund M, Léon C, Amann KU, Gachet C, Hugo CP. Hohenstein B, et al. Among authors: hugo cp. J Am Soc Nephrol. 2007 Feb;18(2):494-505. doi: 10.1681/ASN.2006050439. Epub 2007 Jan 10. J Am Soc Nephrol. 2007. PMID: 17215444

2

Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis.

Floege J, Burg M, Hugo C, Gordon KL, Van Goor H, Reidy M, Couser WG, Koch KM, Johnson RJ. Floege J, et al. J Am Soc Nephrol. 1998 May;9(5):792-801. doi: 10.1681/ASN.V95792. J Am Soc Nephrol. 1998. PMID: 9596076

3

Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ. Kang DH, et al. J Am Soc Nephrol. 2001 Jul;12(7):1434-1447. doi: 10.1681/ASN.V1271434. J Am Soc Nephrol. 2001. PMID: 11423572

4

Role of the microvascular endothelium in progressive renal disease.

Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Kang DH, et al. J Am Soc Nephrol. 2002 Mar;13(3):806-816. doi: 10.1681/ASN.V133806. J Am Soc Nephrol. 2002. PMID: 11856789 Review.

5

P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.

Rost S, Daniel C, Schulze-Lohoff E, Bäumert HG, Lambrecht G, Hugo C. Rost S, et al. Kidney Int. 2002 Nov;62(5):1659-71. doi: 10.1046/j.1523-1755.2002.00621.x. Kidney Int. 2002. PMID: 12371966 Free article.

6

Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo.

Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, Imai E, Hugo C. Daniel C, et al. Am J Pathol. 2003 Sep;163(3):1185-92. doi: 10.1016/s0002-9440(10)63478-5. Am J Pathol. 2003. PMID: 12937160 Free PMC article.

7

Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.

Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C. Daniel C, et al. Kidney Int. 2004 Feb;65(2):459-68. doi: 10.1111/j.1523-1755.2004.00395.x. Kidney Int. 2004. PMID: 14717916 Free article.

8

The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.

Daniel C, Pippin J, Shankland SJ, Hugo C. Daniel C, et al. Lab Invest. 2004 May;84(5):588-96. doi: 10.1038/labinvest.3700078. Lab Invest. 2004. PMID: 15064772 Free article.

9

Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.

Hohenstein B, Daniel C, Wagner A, Stasch JP, Hugo C. Hohenstein B, et al. Am J Physiol Renal Physiol. 2005 Apr;288(4):F685-93. doi: 10.1152/ajprenal.00280.2004. Epub 2004 Nov 23. Am J Physiol Renal Physiol. 2005. PMID: 15561976 Free article.

10

Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis.

Hohenstein B, Kasperek L, Kobelt DJ, Daniel C, Gambaryan S, Renné T, Walter U, Amann KU, Hugo CP. Hohenstein B, et al. Among authors: hugo cp. J Am Soc Nephrol. 2005 Apr;16(4):986-96. doi: 10.1681/ASN.2004070591. Epub 2005 Mar 2. J Am Soc Nephrol. 2005. PMID: 15743999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters